<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 7: Recurrent Pregnancy Loss (RPL) and Progesterone Resistance | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
 flex-shrink: 0;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 16: Advanced Case Studies ‚Ä¢ Lesson 7 of 8</span>
 <h1 class="lesson-title">Recurrent Pregnancy Loss (RPL) and Progesterone Resistance</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üß¨ Advanced Clinical Application</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute Verified</div>
 <div class="title">Clinical Excellence in Reproductive Immunology & Endocrinology</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">Lesson Architecture</span>
 <ul class="toc-list">
 <li><a href="#root-cause"><span class="section-num">01</span>Root Cause Discovery (R)</a></li>
 <li><a href="#resistance"><span class="section-num">02</span>Progesterone Resistance</a></li>
 <li><a href="#nutritional"><span class="section-num">03</span>Targeted Nutritional Support (T)</a></li>
 <li><a href="#metabolic"><span class="section-num">04</span>Metabolic Clearance (O)</a></li>
 <li><a href="#nervous"><span class="section-num">05</span>Nervous System Trauma (R)</a></li>
 <li><a href="#case-study"><span class="section-num">06</span>Clinical Case Application</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>Building on <strong>Module 2 (Endocrine Synergy)</strong> and <strong>Module 5 (Metabolic Clearance)</strong>, this lesson examines the high-stakes intersection of hormonal signaling and immune tolerance in the context of Recurrent Pregnancy Loss.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Navigating the Complexity of Loss</h3>
 <p>Recurrent Pregnancy Loss (RPL) is one of the most heartbreaking challenges a woman can face. While conventional medicine often waits until three losses to investigate, the <strong>R.E.S.T.O.R.E. Method‚Ñ¢</strong> advocates for early, comprehensive root-cause discovery. In this lesson, we will explore why "normal" progesterone levels on a lab report might hide a deeper cellular resistance, and how we can support the delicate endometrial environment for a successful pregnancy.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Educational Objectives</span>
 <ul>
 <li>Analyze the mechanisms of progesterone receptor sensitivity versus serum concentrations in RPL.</li>
 <li>Identify the "Root Cause" drivers of RPL including clotting factors, silent inflammation, and immunological triggers.</li>
 <li>Apply targeted nutritional strategies to optimize corpus luteum function and endometrial receptivity.</li>
 <li>Evaluate the impact of oxidative stress and metabolic clearance on reproductive tissue integrity.</li>
 <li>Implement nervous system regulation tools to manage the psychological trauma of fertility struggles.</li>
 </ul>
 </div>

 <h2 id="root-cause">Investigating Root Cause Discovery (R) Beyond Genetics</h2>
 <p>In the conventional model, Recurrent Pregnancy Loss (defined as two or more consecutive losses) is often attributed to chromosomal abnormalities. While genetic factors account for approximately 50-60% of early losses, the remaining 40% often fall into the "unexplained" category. This is where the hormone health specialist shines.</p>

 <p>Using the <strong>Root Cause Discovery</strong> pillar, we look for physiological drivers that create a hostile environment for the embryo. Key areas of investigation include:</p>

 <ul>
 <li><strong>Thrombophilia (Clotting Factors):</strong> Micro-clots in the developing placenta can disrupt nutrient delivery. We look for Factor V Leiden, Prothrombin mutations, and MTHFR polymorphisms that affect homocysteine levels.</li>
 <li><strong>Reproductive Immunology:</strong> An overactive immune system may perceive the embryo as a "foreign invader." This involves Elevated Natural Killer (NK) cell activity or Antiphospholipid Syndrome (APS).</li>
 <li><strong>Chronic Endometritis:</strong> A "silent" low-grade inflammation of the uterine lining, often asymptomatic, that prevents proper implantation.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>When a client presents with "unexplained" RPL, always look at the <strong>High-Sensitivity C-Reactive Protein (hs-CRP)</strong>. If inflammation is systemic, it is almost certainly affecting the delicate immune-privilege of the uterus.</p>
 </div>

 <h2 id="resistance">The Mechanism of Progesterone Resistance</h2>
 <p>One of the most overlooked factors in RPL is <strong>Progesterone Resistance</strong>. A client may show "sufficient" progesterone levels on a day-21 blood draw (e.g., 15 ng/mL), yet still experience early loss. This occurs because the <em>receptors</em> on the endometrial lining are not responding to the hormone.</p>

 <p>Progesterone resistance is often driven by <strong>Estrogen Dominance</strong> or chronic inflammation. When inflammatory cytokines (like TNF-alpha) are high, they can downregulate the expression of Progesterone Receptor-B (PR-B), the isoform responsible for the "pro-gestational" effects. This results in an endometrial lining that remains "pro-inflammatory" rather than switching to the "receptive" state required for implantation.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Factor</th>
 <th>Conventional Approach</th>
 <th>Functional Approach (R.E.S.T.O.R.E.)</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Progesterone</strong></td>
 <td>Supplement with synthetic progestins.</td>
 <td>Identify <em>why</em> receptors are resistant (e.g., inflammation, gut dysbiosis).</td>
 </tr>
 <tr>
 <td><strong>Loss Definition</strong></td>
 <td>Wait for 3 losses to test.</td>
 <td>Investigate after 1 loss or during preconception if history of PCOS/Endo exists.</td>
 </tr>
 <tr>
 <td><strong>Focus</strong></td>
 <td>Chromosomal/Structural.</td>
 <td>Metabolic, Immunological, and Environmental.</td>
 </tr>
 </tbody>
 </table>

 <h2 id="nutritional">Targeted Nutritional Support (T) for Endometrial Receptivity</h2>
 <p>To support a healthy pregnancy, we must first support the <strong>Corpus Luteum</strong>‚Äîthe temporary endocrine gland that produces progesterone. Using the <strong>Targeted Nutritional Support</strong> pillar, we focus on specific micronutrients that enhance both hormone production and receptor sensitivity.</p>

 <ul>
 <li><strong>Vitamin C:</strong> A landmark study by <em>Henmi et al. (2003)</em> found that 750mg of Vitamin C daily increased progesterone levels and improved pregnancy rates in women with luteal phase defects.</li>
 <li><strong>Vitamin B6 (Pyridoxine):</strong> Essential for the modulation of steroid hormone receptors. It helps "reset" the receptors so they can better receive the progesterone signal.</li>
 <li><strong>Zinc:</strong> Vital for the pituitary gland to release Follicle Stimulating Hormone (FSH), which eventually leads to a stronger corpus luteum.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Clinical Pearl</span>
 <p>Don't forget <strong>Selenium</strong>. It supports the antioxidant defense in the follicular fluid, protecting the egg from oxidative damage before it is even fertilized.</p>
 </div>

 <h2 id="metabolic">Optimizing Metabolic Clearance (O) and Oxidative Stress</h2>
 <p>The <strong>Optimizing Metabolic Clearance</strong> pillar is critical for RPL because the "Estrobolome" (the gut's estrogen-processing bacteria) dictates the estrogen-to-progesterone ratio. If a woman cannot clear used estrogens through Phase II liver detoxification (methylation/glucuronidation), the resulting estrogen dominance can further exacerbate progesterone resistance.</p>

 <p>Furthermore, high levels of <strong>oxidative stress</strong> in the reproductive tissues can lead to DNA fragmentation in the embryo. We use "Clearance" strategies like:</p>
 <ul>
 <li><strong>N-Acetyl Cysteine (NAC):</strong> To boost glutathione levels and reduce inflammation in the uterine environment.</li>
 <li><strong>Sulforaphane (from Broccoli Sprouts):</strong> To induce Phase II enzymes and clear inflammatory estrogen metabolites like 16-OH estrone.</li>
 </ul>

 <h2 id="nervous">Regulating the Nervous System (R): The Trauma of Loss</h2>
 <p>We cannot ignore the <strong>Neuro-Endocrine Connection</strong>. Recurrent loss creates a state of chronic sympathetic dominance (fight-or-flight). The HPA axis and HPG axis are intimately linked; high cortisol can inhibit the pulsatile release of GnRH, leading to lower LH levels and a "weak" ovulation.</p>

 <p>Practitioners must guide clients through <strong>Nervous System Regulation</strong>. This isn't just about "stress management"‚Äîit's about moving the body out of a trauma response so the biological "safety" signal can be sent to the reproductive system.</p>

 <!-- Case Study -->
 <div class="case-study" id="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üìã</div>
 <div>
 <p class="title">Clinical Case Study</p>
 <p class="subtitle">Sarah, 31: The "Chemical Pregnancy" Cycle</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div class="patient-avatar">S</div>
 <div class="patient-info">
 <h4>Sarah, 31 years old</h4>
 <p>3 early "chemical" pregnancies in 12 months. Short luteal phase (9 days).</p>
 </div>
 </div>
 <p><strong>The Presentation:</strong> Sarah was told by her OBGYN that her losses "didn't count" as RPL because they were early chemical pregnancies. She felt dismissed and traumatized. Her labs showed a Day 21 Progesterone of 11 ng/mL‚Äîclinically "normal" but suboptimal for sustaining pregnancy.</p>
 
 <p><strong>The R.E.S.T.O.R.E. Intervention:</strong></p>
 <ul>
 <li><strong>Root Cause (R):</strong> Found high anti-TPO antibodies (Subclinical Hashimoto's) and MTHFR C677T homozygous mutation.</li>
 <li><strong>Targeted Nutrition (T):</strong> Methylated B-complex, 1000mg Vitamin C, and 200mcg Selenium.</li>
 <li><strong>Metabolic Clearance (O):</strong> Added Calcium D-Glucarate to assist with estrogen clearance and reduce receptor competition.</li>
 <li><strong>Nervous System (R):</strong> Daily HRV (Heart Rate Variability) tracking and 10 minutes of box breathing to lower the "threat" response.</li>
 </ul>
 <p><strong>The Outcome:</strong> After 4 months of protocol, Sarah's luteal phase extended to 13 days. She conceived again and, with the addition of low-dose aspirin (for the MTHFR/clotting risk) and continued nutritional support, carried the pregnancy to full term.</p>
 </div>
 </div>

 <div class="coach-tip">
 <span class="tip-label">Empathy in Practice</span>
 <p>For women over 40 or those pivoting careers into this space, your empathy is your greatest asset. Many of your clients have been "gaslit" by the medical system. Using the term "Recurrent Pregnancy Loss" rather than "Miscarriage" can sometimes feel more validating of the physiological complexity they are facing.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why might a woman with "normal" serum progesterone levels still experience RPL?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Due to Progesterone Resistance, where endometrial receptors (specifically PR-B) are downregulated by inflammation or estrogen dominance, making the cells "deaf" to the hormone signal.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What was the specific finding in the Henmi et al. (2003) study regarding Vitamin C?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The study found that 750mg of Vitamin C daily increased progesterone levels and improved pregnancy rates in women with luteal phase defects.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. How does the "Optimizing Metabolic Clearance" pillar relate to RPL?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It ensures that excess or "dirty" estrogens are cleared from the system, preventing estrogen dominance which can interfere with the progesterone-to-estrogen ratio and increase oxidative stress in reproductive tissues.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Which micronutrient is specifically mentioned for protecting follicular fluid from oxidative damage?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Selenium.</div>
 </div>
 </div>

 <!-- Takeaways Box -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways for the Specialist</p>
 <ul>
 <li>RPL is rarely "unexplained" when viewed through the lens of systems biology and the R.E.S.T.O.R.E. Method‚Ñ¢.</li>
 <li>Always address the "soil" (the endometrium) by reducing inflammation and optimizing receptor sensitivity.</li>
 <li>Progesterone resistance is a cellular communication issue, not just a volume issue.</li>
 <li>Nervous system regulation is a physiological requirement for pregnancy, as it signals "safety" to the HPO axis.</li>
 <li>Practitioners can provide immense value‚Äîand generate significant income ($300+ per consultation)‚Äîby specializing in this complex, underserved niche.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Henmi, H., et al. (2003). "Effect of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect." <em>Fertility and Sterility</em>.</li>
 <li>Practice Committee of the American Society for Reproductive Medicine. (2020). "Evaluation and treatment of recurrent pregnancy loss: a committee opinion." <em>Fertility and Sterility</em>.</li>
 <li>Young, S. L. (2013). "Role of endometrial receptivity in established reproduction and in the etiology of infertility." <em>Journal of Assisted Reproduction and Genetics</em>.</li>
 <li>Bulun, S. E., et al. (2010). "Progesterone resistance in endometriosis: link to failure to metabolize estradiol." <em>Molecular and Cellular Endocrinology</em>.</li>
 <li>Vissenberg, R., et al. (2015). "TPO-antibodies and recurrent pregnancy loss: a systematic review and meta-analysis." <em>Human Reproduction Update</em>.</li>
 <li>Szekeres-Bartho, J., et al. (2008). "The role of progesterone in feto-maternal immunological tolerance." <em>Journal of Reproductive Immunology</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>

</body>
</html>